The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Klabukova D.L.

Russian University of Medicine

Krysanov I.S.

Russian University of Medicine;
Medical Institute of Continuing Education of the Russian Biotechnological University

Krysanova V.S.

Medical Institute of Continuing Education of the Russian Biotechnological University

Ermakova V.Yu.

I.M. Sechenov First Moscow State Medical University (Sechenov University);
OOO Institut kliniko-ekonomicheskoi ekspertizy i farmakoekonomiki

Indirect comparison of anti-angiogenic agents in the treatment of diabetic macular edema

Authors:

Klabukova D.L., Krysanov I.S., Krysanova V.S., Ermakova V.Yu.

More about the authors

Journal: Russian Annals of Ophthalmology. 2024;140(6): 69‑79

Views: 961

Downloaded: 2


To cite this article:

Klabukova DL, Krysanov IS, Krysanova VS, Ermakova VYu. Indirect comparison of anti-angiogenic agents in the treatment of diabetic macular edema. Russian Annals of Ophthalmology. 2024;140(6):69‑79. (In Russ.)
https://doi.org/10.17116/oftalma202414006169

Recommended articles:
Physical reha­bilitation in sarcopenia: modern approaches. (A lite­rature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(3):56-61
The role of glutamine in the treatment of severe acute pancreatitis. Russian Journal of Anesthesiology and Reanimatology. 2024;(4):97-101
The role of immuno-inflammatory factors in the deve­lopment of nega­tive symptoms in schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):42-48

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.